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Comparison of Surgical Septal
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With Cardiac Magnetic Resonance Imaging in
Patients With Hypertrophic Obstructive Cardiomyopathy
Uma S. Valeti, MD,* Rick A. Nishimura, MD,* David R. Holmes, MD,* Philip A. Araoz, MD,†
James F. Glockner, MD,† Jerome F. Breen, MD,† Steve R. Ommen, MD,*
Bernard J. Gersh, MB, CHB, DPHIL,* A. Jamil Tajik, MD,* Charanjit S. Rihal, MD,*
Hartzell V. Schaff, MD,‡ Barry J. Maron, MD§
Rochester and Minneapolis, Minnesota
Objectives This study sought to describe the acute morphologic differences that result from septal myectomy and alcohol
septal ablation using cardiac magnetic resonance (CMR) imaging.
Background Surgical septal myectomy and alcohol septal ablation relieve left ventricular outflow tract obstruction in severely
symptomatic patients with hypertrophic cardiomyopathy (HCM).
Methods Cine and contrast-enhanced CMR images were obtained in HCM patients before and after septal myectomy
(n  24) and alcohol septal ablation (n  24). Location of septal reduction, extent of myocardial necrosis, and
conduction system abnormalities with each technique were compared.
Results With septal myectomy, there was a discrete area of resected tissue consistently localized to anterior septum. In
contrast, alcohol septal ablation resulted in a more variable effect. In most patients, alcohol septal ablation
caused a transmural region of tissue necrosis, located more inferiorly in the basal septum than myectomy and
usually extending into the right ventricular side of the septum at the midventricular level. However, there were 6
patients after alcohol septal ablation in whom there was sparing of the basal septum with residual gradients at
follow-up. After the procedure, left bundle branch block developed in 46% of septal myectomy patients, and
right bundle branch block was evident in 58% of alcohol septal ablation patients.
Conclusions Septal myectomy and alcohol septal ablation for severely symptomatic, drug-refractory patients with obstructive
HCM have different morphologic effects and location sites on left ventricular septal myocardium. Septal myec-
tomy provides consistent resection of the obstructing portion of the anterior basal septum, whereas the effect of
ethanol septal ablation is more variable. These findings may have important implications for patient selection
and management as well as long-term outcome. (J Am Coll Cardiol 2007;49:350–7) © 2007 by the American
College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.08.055i
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an an important subset of patients with hypertrophic car-
iomyopathy (HCM), dynamic left ventricular (LV) out-
ow tract obstruction causes disabling heart failure symp-
oms (1,2). In patients unresponsive to pharmacologic
herapy, surgical septal myectomy has been the accepted
rimary treatment intervention for relieving obstruction and
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ccepted August 8, 2006.mproving symptoms (3–5). Alcohol septal ablation with a
ercutaneous catheter approach has recently emerged as a
reatment alternative to surgery in selected patients (6,7).
See page 358
lthough some clinicians regard these 2 strategies for
entricular septal reduction as comparable treatment mo-
alities (8,9), there may be important differences between
hese 2 techniques, with potential impact on short-term and
ong-term outcome. In the present study, we investigated
nd compared the in vivo acute anatomical consequences
fter surgical septal myectomy and percutaneous alcohol
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January 23, 2007:350–7 Septal Myectomy and Alcohol Ablationeptal ablation, using cine steady-state free precession and
elayed contrast-enhanced images obtained by cardiac mag-
etic resonance (CMR) imaging.
ethods
atient population. Patients with obstructive HCM who
nderwent alcohol septal ablation (between May 2003 and
une 2005) or isolated surgical septal myectomy (between
pril 2004 and June 2005) and had both a pre-
rocedure and post-procedure CMR study were included in
his study. Twenty-four patients with alcohol septal ablation
nd 24 patients with septal myectomy were prospectively
tudied with paired CMR studies and constitute the study
roup.
The clinical indication for surgery and ablation was an LV
utflow tract gradient50 mm Hg at rest or with provocation,
nd New York Heart Association (NYHA) functional class III
r IV symptoms refractory to maximal medical management
4). Septal myectomy was offered as the primary treatment in
hese patients. Alcohol septal ablation was offered as an
lternative for those patients who did not wish to undergo
peration. The final choice of the therapeutic procedure
myectomy vs. ablation) was based on patient and physician
reference after analysis of the individual clinical profile (in-
luding age) and full discussion of the risks and benefits of both
rocedures performed at Mayo Clinic.
During the time periods of the study, there were a total of
17 septal reduction procedures performed (47 alcohol
eptal ablation and 61 isolated myectomy procedures).
hose patients not included in the study group had either
mplantable defibrillators or pacemakers in place, refused a
MR study because of claustrophobia or other reasons, or
ere otherwise judged clinically unsuitable for this protocol.
n 7 of the 47 patients undergoing alcohol septal ablation,
eart block developed requiring a permanent pacemaker,
hich excluded them from the study. No patients under-
oing myectomy developed heart block. All subjects gave
nformed consent for the septal reduction procedures, and
his study was approved by the institutional review board.
eptal myectomy technique. Surgical septal myectomy
as performed using a modification of the procedure
escribed by Morrow (5,10,11). Briefly, myectomy was
erformed through an aortotomy after induced cardiac
systole with cold blood cardioplegia. Myectomy creates a
ectangular trough via 2 parallel incisions in the basal
eptum. These incisions are then connected proximally
elow the aortic valve and extended distally to beyond the
evel of mitral–septal contact and subaortic obstruction, and
n some patients to the base of the papillary muscles (i.e.,
xtended myectomy). Intraoperative transesophageal echocar-
iography was performed in all patients to document relief of
bstruction and mitral regurgitation after myectomy (12).
lcohol septal ablation technique. Alcohol septal abla-
ion was performed as previously described (6,11). A tem-
orary ventricular pacing catheter was placed via the right mnternal jugular vein before per-
orming the ablation. Transeptal
eft heart catheterization was
erformed, and high-fidelity
icromanometer-tipped cathe-
ers for continuous measurement
f left atrial and LV pressures
ere placed. A multipurpose
atheter was placed in the aortic
oot to measure the aortic pres-
ure. Coronary angiography was
erformed to identify the appro-
riate septal perforator artery,
hich was then cannulated with
0.014-inch guidewire. The
ost proximal septal artery that
ould undergo cannulation was selected as the initial artery.
low- to medium-compliance coronary angioplasty balloon
as used to occlude the proximal septal perforator artery,
nd localization of the area of perfusion was performed
sing contrast echocardiography (11,13). One to 2 ml of
0% dilute Perflutren lipid microspheres were injected into
he distal end of the balloon while imaging from the apical
pproach. If the area of perfusion on the septum was not the
rea of contact by systolic anterior motion of the mitral
alve, another septal perforator was cannulated. One to 3 ml
f absolute alcohol were injected slowly over 5 to 15 min
nto the septal perforator artery under echocardiographic
uidance to cause a localized infarction. The direct pressure
radient between the LV and aorta was recorded continu-
usly. A second perforator artery was cannulated and
blated if gradient reduction 50% was not achieved after
he first septal ablation.
MR imaging. Cardiovascular magnetic resonance imag-
ng was performed before myectomy or ablation and again 3
o 7 days after the procedure in all patients. All scans were
erformed on a 1.5-T GE Signa Excite Twin Speed clinical
canner (General Electric Medical Systems, Milwaukee,
isconsin) using a 4- or 8-element cardiac phased-array
eceiver coil. Images were acquired using electrocardiogram
ECG) gating during multiple short breath holds (8 to 15 s).
Functional performance of the ventricles was assessed
sing cine steady-state free-precession images. An initial
-chamber view was obtained, followed by multiple parallel
hort-axis slices (8-mm slice thickness, 2-mm gap) every 10
m covering the entire ventricle from base to apex. To
erform a detailed assessment of the dynamics of mitral–
eptal interaction, we obtained 10 radial long-axis views 10°
part to cover the entire LV outflow tract (a basal short-axis
lice was used as a reference to prescribe the radial slices).
ypical scan parameters for the ECG-gated segmented
-space steady-state free-precession sequence were as fol-
ows: repetition time/echo time/temporal resolution/matrix/
ip angle/bandwidth/views per segment 3.5 ms/1.6 ms/40
Abbreviations
and Acronyms
CMR  cardiac magnetic
resonance
ECG  electrocardiogram
HCM  hypertrophic
cardiomyopathy
LBBB  left bundle branch
block
LV  left ventricular
NYHA  New York Heart
Association
RBBB  right bundle
branch blocks/224  160/45°/125 kHz/8 to 16.
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Septal Myectomy and Alcohol Ablation January 23, 2007:350–7Delayed-enhancement images for detection of tissue
ecrosis were obtained approximately 10 min after injection
f intravenous gadolinium-diethylenetriaminepentaacetic
cid (0.2 mmol/kg) using a segmented inversion recovery
repared fast gradient echo sequence (14). The prescription
or this sequence was identical to the short-axis cine
equence to ensure image registration. Typical scan param-
ters were as follows: repetition time/echo time/inversion
ime/matrix/flip angle/bandwidth/views per segment 6.5
s/3.1 ms/175 to 225 ms/256  192/20°/31.2 kHz/24.
nalysis of CMR images. SHORT-AXIS CINE IMAGES.
hort-axis cine images were used to calculate maximal LV
all thickness and mass based on endocardial and epicardial
ontours traced at end-diastole. Papillary muscles and
rominent trabeculations were included in the mass calcu-
ations. The LV ejection fraction was calculated based on
ndocardial contours traced using computer-assisted
lanimetry at end-diastole and end-systole.
OCALIZATION AND QUANTITATION OF SEPTAL REDUC-
ION SITE. For the purpose of analysis, ventricular septum
as divided into anterior and inferior segments and LV free
all as previously described (15). The area of septal reduc-
ion in myectomy patients was identified from the short-axis
nd radial long-axis cine images as a distinctive trough in
he basal anterior septum. In patients who underwent
lcohol ablation, the tissue necrosis site was visualized as a
egion of hyperenhancement on the post-gadolinium contrast-
nhanced images.
The area of tissue necrosis after alcohol septal ablation
as calculated by the Simpson method using planimetry of
he hyperenhanced area on the delayed contrast-enhanced
cans. New areas of hyperenhancement on the post-ablation
MR (i.e., not present on the pre-ablation scan) were
onsidered to represent tissue necrosis caused by the proce-
ure (16). Areas of hyperenhancement identified in the
re-procedural scans were attributed to pre-existing fibrosis
nd were not included in the calculation of the infarct mass
17). Central areas of hypoenhancement within the region
f hyperenhancement were judged to be central no-flow
ones in the core of tissue necrosis, and were included in the
alculation of the tissue necrosis size. Hyperenhancement
nvolving 75% of the thickness of the septum was re-
arded as near transmural.
Preprocedural and post-procedural images were by design
nalyzed side-by-side (to accurately match cross-sectional
lices) and interpreted without prior knowledge of whether
he patients had undergone either myectomy or ablation,
nd as the consensus of 2 observers (U.S.V. and P.A.A.).
ecause of the differences in the post-procedure CMR
mages between septal ablation and septal myectomy, blind-
ng was not possible. All contours were manually drawn and
nalyzed using a standard commercially available software
ackage (MASS 5.0, Medis Medical Imaging Systems,
eiden, the Netherlands).
VCG. Resting 12-lead ECGs were obtained before and
4 h after the procedure and were analyzed for conduction
bnormalities blindly without knowledge of the CMR
ndings. The abnormal patterns coded were left bundle
ranch block (LBBB), right bundle branch block (RBBB),
nd intraventricular conduction delay.
tatistics. An unpaired Student t test was used to compare
ontinuous variables between the 2 groups, and chi-square
nalysis was used to compare categorical variables. Statistical
ignificance was defined as p  0.05.
esults
emographics and procedural results. PATIENT POPULA-
ION. Demographics of the 2 patient populations are
hown in Table 1. In comparison to the ablation group,
atients undergoing myectomy were younger (50 20 years
s. 62  12 years, p  0.03). Pre-procedural LV outflow
radients were similar (75  41 mm Hg vs. 76  40 mm
g, p  NS). Nineteen patients undergoing myectomy and
8 patients undergoing ablation had resting gradients 50
m Hg. The remaining patients had provocable gradients
50 mm Hg using amyl nitrite (7 patients), isoproterenol (3
atients), and exercise (1 patient).
URGICAL MYECTOMY. In the 24 myectomy patients, LV
utflow tract gradients measured in the operating room
ecreased from 75 41 to 3 3 mm Hg immediately after
yectomy. The amount of resected muscle was 6  4 g by
eight. The ECGs performed 24 h after the procedure
howed complete LBBB in 11 of 24 patients (46%), and no
atient developed heart block.
LCOHOL SEPTAL ABLATION. Alcohol septal ablation was
erformed using the first septal perforator artery in 20 of
4 patients; 3 patients required ablation of both the first
nd second septal perforators, and another patient had
blation of a septal perforator originating from the
roximal circumflex artery. The mean volume of alcohol
njected was 1.7  0.4 ml. The LV outflow gradient as
easured in the catheterization laboratory decreased
linical Features of Hypertrophicardiomyopathy Patients Withu g cal Myectomy or Alcohol Septal Ablation
Table 1
Clinical Features of Hypertrophic
Cardiomyopathy Patients With
Surgical Myectomy or Alcohol Septal Ablation
Septal
Myectomy
(n  24)
Alcohol Septal
Ablation
(n  24)
Age (yrs) 50 20 62 12*
Gender (male/female) 15/9 12/12
LVOT gradient preprocedure (mm Hg) 75 41 76 40
LVOT gradient immediately
postprocedure (mm Hg)
3 3 7 6
Ventricular septal thickness
preprocedure (mm)
22 4 23 4
LV mass preprocedure (g) 220 88 216 104
Ejection fraction preprocedure (%) 68 7 69 9alues are expressed as mean  SD. *p  0.05 versus septal myectomy.
LV  left ventricular; LVOT  left ventricular outflow tract.
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January 23, 2007:350–7 Septal Myectomy and Alcohol Ablationrom 76  40 to 7  6 mm Hg immediately after the
rocedure. The ECGs performed 24 h after the proce-
ure showed that 14 patients (58 %) developed RBBB,
a complete LBBB, and 1 transient LBBB. Mean
roponin T values 36 h after the ablation were 2.35 
.83 ng/ml. Of the total of 47 ablations performed during
his time period, 8 patients had heart block requiring
ermanent pacemakers (17%). These 8 patients were a
riori excluded from the study because a post-procedure
MR could not be performed.
ite and extent of septal reduction by CMR. MYECTOMY.
he myectomy site was confined to the LV aspect of the
asal anterior septum in all 24 patients (Figs. 1 and 2). In 14
atients the septal resection extended distally into the
idventricle in anterior septum at the papillary muscle level.
eptal thickness at the site of resection site was 22  5 mm
range 16 to 33 mm) preoperatively and decreased to 11 
mm (range 5 to 20 mm) postoperatively.
LCOHOL SEPTAL ABLATION. The site of targeted septal
eduction with alcohol ablation differed morphologically
rom that of myectomy with respect to location and extent
Figs. 1 and 3). The extent and distribution of the tissue
Figure 1 Schematic Representation of the Differing Effects of S
Contrasting anatomical consequences of extended surgical septal myectomy show
at myectomy is from the left ventricular side of the basal anterior septum. (B) The
posteriorly and inferiorly in the basal anterior septum than is the case for myectom
septum either with transmural distribution or predominantly the right ventricular poecrosis was variable. In 18 of 24 patients, the tissue
ecrosis was transmural and located predominantly at the
unction of anterior and inferior septum in the basal LV,
nd extended into the inferior portion of the septum at the
idventricular level involving primarily the right ventricular
ortion. In comparison with the septal region resected by
eptal myectomy, this area of tissue necrosis was more
nferior within the septum (Fig. 3). In 5 patients the most
roximal basal septum was unaffected by the alcohol septal
blation with the tissue necrosis involving a more distal area
f the septum. In these 5 patients, the tissue necrosis
nvolved primarily the right ventricular side of the septum
Fig. 4). In 1 patient, the tissue necrosis was not transmural
nd confined to the LV side of the septum.
The calculated proportion of LV mass occupied by tissue
ecrosis was 8  4% (range 3.6% to 13.6%); the average
stimated size was 16  7 g. Each of the 24 patients also
ad central areas of hypoenhancement within the hyperen-
anced infarct area, representing no-flow zones of variable
izes in the core of the tissue necrosis (Fig. 3). The
rominent differences between these 2 septal reduction
echniques are summarized in Table 2.
l Reduction Therapies
e short-axis plane (A) and alcohol septal ablation (B). (A) The tissue resected
necrosis resulting from alcohol ablation is usually transmural and located more
midventricular level (lower row of B), the tissue necrosis involves the inferior
f the septum.epta
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Septal Myectomy and Alcohol Ablation January 23, 2007:350–7hort-term follow-up. Combined clinical and echocardio-
raphic follow-up was obtained in 45 of 48 patients (94%).
here were 23 of 24 myectomy and 22 of 24 alcohol septal
blation patients in whom this follow-up could be obtained.
he mean follow-up time was 440  180 days.
YECTOMY. All 23 patients have remained symptom free
nd without recurrence of gradients at follow-up. No
atient required a permanent pacemaker. One patient de-
eloped a left hemispheric stroke 2 weeks after the myec-
omy. The mean follow-up LV outflow tract gradient was
20 mm Hg in all 23 patients (mean 7  6 mm Hg). No
atient has required a repeat procedure.
LCOHOL SEPTAL ABLATION. There were no deaths in the
2 patients in whom both clinical and echocardiography
ollow-up could be obtained. One patient developed symptom-
tic sustained ventricular tachycardia 2 weeks after discharge
equiring electrophysiological ablation of the tachycardia.
here were 16 patients who had improvement of symptoms
ith a residual resting LV outflow gradient 20 mm Hg. Six
atients had a residual resting LV outflow gradient 20 mm
g. One of these patients underwent septal myectomy for
evere residual symptoms at 6-month follow-up. Two other
Figure 2 CMR Image in Surgical Myectomy Patients
Short-axis plane cardiovascular magnetic resonance (CMR) image of the basal
left ventricle (LV) from 3 hypertrophic cardiomyopathy patients showing the
area of septal myectomy before (left), 3 to 7 days after surgery (center), and
also 3 to 7 days after myectomy after the administration of gadolinium (right).
Arrows show the area and extent of the muscular septal resection. In the post-
gadolinium images, normal myocardium appears dark and necrotic (infarcted)
myocardium appears white. There is no evidence of intramyocardial delayed
hyperenhancement at or near the myectomy site, indicating the absence of
necrotic tissue. RV  right ventricle.atients remained in NYHA functional class 3 but elected toontinue medical therapy. Two patients had residual NYHA
unctional class 2 symptoms and elected to continue medical
herapy. One patient had dramatic improvement in symptoms
ut had a resting gradient 100 mm Hg at follow-up.
Of the 6 patients with residual LV outflow gradients, the
mmediate post-procedure CMR had shown that 5 had
paring of the basal septum. Of these 5 patients with sparing
f the basal septum, 4 had nontransmural tissue necrosis of
he right ventricular side of the septum (Fig. 4). There was
patient with a residual gradient who was shown to have a
mall nontransmural region of tissue necrosis that involved
nly the LV side of the septum and the basal anterior wall.
Follow-up CMR studies were obtained in 10 patients at
n average of 6 months (176  11 days). The mean
eduction in septal thickness was 6 mm. The mean thickness
t the site of tissue necrosis before procedure was 23  4.5
m (range 17 to 29 mm) and decreased to 17  5 mm
range 13 to 25 mm) at follow-up. In the patients with
paring of the basal septum on the immediate post-
rocedure CMR scan, there was thinning of the more distal
Figure 3 CMR Image in Alcohol Ablation Patients
Short-axis plane cardiovascular magnetic resonance (CMR) image of the basal
left ventricle (LV) from 3 hypertrophic cardiomyopathy patients showing pre-
ablation morphology (left panels) and the area of the septal ablation created
by infusion of alcohol on the post-gadolinium images (center, right panels).
The images in the right panel are identical to those in the center panel and
highlight the area of the infarct with broken lines. Post-ablation images (after
gadolinium) show large areas of transmural hyperenhancement with irregular
borders, indicative of necrotic tissue (white) in the region of the targeted abla-
tion. Arrow shows an inhomogeneous area within the core of an infarct in
which gadolinium uptake is absent because of severe microvascular obstruc-
tion (center patient). RV  right ventricle.
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January 23, 2007:350–7 Septal Myectomy and Alcohol Ablationeptum with the basal septum remaining unchanged in
hickness (Fig. 5).
iscussion
he purpose of the present investigation was to compare the
natomical sequelae of surgical septal myectomy versus
lcohol septal ablation using CMR. There were substantial
ifferences in the anatomical effects of these 2 techniques
nvolving both the location and extent of myocardial in-
olvement. These findings explain the differences in the
cute outcomes of these techniques and may have important
mplications regarding long-term outcomes.
With septal myectomy, there was a discrete area of
esected tissue localized to the anterior septum. The region
f septal reduction was a consistent finding in all patients.
here was a 50% reduction in thickness of the basal septum.
t follow-up, the residual gradient was 20 mm Hg in all
atients, and all patients were asymptomatic.
Alternatively, there was a more varied effect of alcohol
eptal ablation. In 75% of patients there was a transmural
Figure 4 CMR Image After Septal
Ablation With Residual Obstruction
Long-axis cardiovascular magnetic resonance (CMR) image views after alcohol
septal ablation on a post-gadolinium study. There is sparing of the proximal
basal septum (white arrow). The region of the hyperenhancement involves
mainly the right ventricular side of the ventricular septum (black arrows). This
patient had the most proximal septal perforator cannulated with apparent local-
ization to the basal septum on contrast echocardiography during the ablation
procedure. LA  left atrium; LV  left ventricle.
omparison of Anatomical Differences Between Surgical Myectomy
Table 2 Comparison of Anatomical Differences Between Surgic
Septal Myectomy
Site of septal reduction Left ventricular side of the sep
and midventricular level
Depth of resection/ablation Average depth  10 mm
Mass of resection/ablation 6  4 gResection/ablation of protruding basal septum All patientsegion of tissue necrosis located inferiorly in the basal
eptum, extending onto the right ventricular side of the
eptum at the midventricular level. The amount of tissue
ecrosis was variable but averaged 8% of overall LV mass,
hich is similar to that reported by Van Dockum et al.
18,19). Although the most proximal septal perforator artery
as initially used with echocardiographic contrast guidance
uring performance of the alcohol septal ablation, there
ere 6 patients who had sparing on the proximal basal
eptum with residual gradients at follow-up. These patients
ad a nontransmural tissue necrosis, usually involving the
ight ventricular side of the septum. The suboptimal results
ssociated with right ventricular septal infarction have been
escribed previously (18,19). The average overall reduction
n basal septal thickness was 26%.
linical implications. The major finding in our study was
he uniform resection of proximal basal septal muscle in the
nterior distribution by septal myectomy, resulting in com-
lete relief of obstruction in all patients. This consistent area
f resection is related to the direct visualization of the
Alcohol Septal Ablation
yectomy and Alcohol Septal Ablation
Alcohol Septal Ablation
t basal More inferior location in basal and midventricular septum, usually
extends into right ventricular side of septum at midventricular level
Predominantly transmural in basal septum; usually nontransmural in
midventricular septum
16  7 g
Figure 5 CMR Image After Septal
Myectomy Versus Septal Ablation
Top panels show long-axis cardiovascular magnetic resonance (CMR) imaging
views before (left) and after (right) septal myectomy. The portion of basal sep-
tum evident in this plane, projecting into the left ventricular (LV) outflow tract,
has been resected at myectomy (arrows). Bottom panels show long-axis views
before (left) and 5 months after (right) septal ablation. The ablation has
spared the most proximal portion of basal septum at the level of systolic ante-
rior motion and mitral valve-septal contact, involving only the more distal sep-
tum below this level of obstruction (arrows). AML  anterior mitral leaflets;
Ao  aorta; LA  left atrium; RV  right ventricle.and
al M
tum aMost proximal basal septum spared in 25% of patients
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Septal Myectomy and Alcohol Ablation January 23, 2007:350–7bstructing septum at the time of operation. This is opposed
o alcohol septal ablation, in which there was a more
ariable location of the area of necrosis. In alcohol septal
blation the operators are still confined to the anatomical
istribution of the available septal perforator arteries, and
here may not be an artery that can be cannulated that
upplies directly the basal septum. The use of echocardio-
raphic contrast to guide selection of a septal perforator has
een proposed to ensure that the area of the tissue necrosis
s the region of the obstruction (13,20). This echocardio-
raphic contrast guidance may be affected by acoustic
hadowing, and thus the very basal septal region may not be
ble to be consistently assessed using echocardiographic
ontrast guidance.
At follow-up, there was an overall higher residual ob-
truction after septal ablation versus septal myectomy. This
n part is because of the patients in whom the ablation
pared the basal septum. However, the location of septal
eduction by these 2 techniques may also influence the
utcome. The region of systolic anterior mitral valve to
eptal contact is usually located in a more anterior region of
he septum, with the obstruction formed by the anterior
eptum, anterior free wall, and mitral valve. This is the
egion that is directly targeted by septal myectomy. Alcohol
eptal ablation targeted a more inferior region of the
entricular septum.
The location of the septal reduction by myectomy and
blation explains the differential effects on the conduction
ystem (11,21). The course of the right bundle branch is
long the right ventricular side of the inferior septum, and
hus is frequently damaged by the transmural region of
issue necrosis produced by septal ablation, as occurred in
bout one-half of our patients who developed RBBB.
omplete heart block has been reported in 10% to 20% of
atients after septal ablation when additional segments of
he left bundle branch are affected. In contrast, septal
yectomy interrupts the left bundle branch coursing in the
nterior septum. Complete heart block is particularly un-
ommon in the absence of pre-existing RBBB (1%)
ecause the right bundle branch is rarely affected by the
uscular resection (11,22). The rarity of complete heart
lock (and the necessity for pacemakers) after myectomy is
elated to the experience and ability of the surgeon to avoid
omplete interruption of the conduction system.
The morphologic appearance after alcohol septal ablation
n CMR scanning is one of a myocardial infarction. It is
nknown whether the long-term consequences of myocar-
ial infarction from septal ablation may produce an arrhyth-
ogenic substrate and possible trigger for sudden cardiac
eath (3,23). There have been several reports of sustained
entricular arrhythmias and even sudden death shortly after
lcohol ablation (24,25). At the present time, however, the
elatively short-term follow-up available after septal ablation
recludes precise knowledge regarding the magnitude of
hat risk, especially because sudden death caused by ventric-
lar arrhythmia may occur in HCM unpredictably decadesfter diagnosis (2,4). Systematic long-term follow-up stud-
es of patients undergoing this procedure will be necessary to
etermine whether the alcohol-induced myocardial infarc-
ion poses an increased risk for ventricular arrhythmias of
udden death.
tudy limitations. The CMR studies comprising this in-
estigation were assembled prospectively, but were not
btained consecutively, largely because of certain unavoid-
ble patient exclusion criteria for CMR imaging. These
atients may not represent the overall population undergo-
ng ablation as 17% of patients were excluded because of the
equirement for a permanent pacemaker. Clinical follow-up
nd repeat follow-up CMR studies were incomplete, but the
ajor purpose of this study was to examine the acute
natomical effect of the 2 septal reduction therapies. There
s a learning curve to performing alcohol septal ablation, and
he optimal results occur with experienced operators
26,27). This current study was performed when more than
00 alcohol septal ablations had been performed by the
perators. Nonetheless, further improvements in the tech-
ique of performing septal ablations may result in better
utcomes.
onclusions. Surgical septal myectomy and alcohol septal
blation for severely symptomatic drug-refractory patients
ith obstructive HCM have different effects on ventricular
eptal myocardium. Septal myectomy provides a consistent
esection of the obstructing portion of the anterior basal
eptum. The effect of alcohol septal ablation is more variable
ith sparing of the basal septum in some patients. The
echanism of septal ablation is creation of a transmural
egion of tissue necrosis, located more inferiorly than
yectomy. Differences in anatomical sequelae between
hese 2 treatment modalities may have important potential
mplications for patient selection and management, as for
ell as long-term outcome.
eprint requests and correspondence: Dr. Rick A. Nishimura,
00 First Street SW, Rochester, Minnesota 55905. E-mail:
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